[Hereditary changes of apolipoproteins B and E]

Area of Science:

• Cardiovascular Science
• Metabolic Disorders
• Lipid Metabolism

Context:

• Accelerated atherosclerosis is observed in patients with type III hyperlipoproteinemia and familial hypercholesterolemia.
• Lipoprotein remnants, including chylomicron remnants and very-low-density lipoprotein (VLDL) remnants/intermediate-density lipoprotein (IDL), accumulate in type III hyperlipoproteinemia, correlating with coronary disease.
• Defective apolipoprotein E (Apo E) impairs normal receptor-mediated catabolism of these lipoproteins.

Purpose:

• To elucidate the mechanisms linking specific dyslipidemias to atherogenesis.
• To understand the role of macrophages in the development of atherosclerotic lesions.
• To identify the molecular interactions between lipoproteins and macrophage receptors.

Summary:

• Type III hyperlipoproteinemia involves accumulating intestinal and hepatic lipoprotein remnants, linked to coronary disease, due to defective Apo E.
• Familial hypercholesterolemia is characterized by elevated IDL from defective LDL receptors, and familial defective Apo B100 increases LDL due to impaired LDL receptor interaction.
• Macrophages, derived from monocytes, are central to atherogenesis, acting as progenitors of foam cells by expressing receptors for chylomicron remnants, VLDL remnants, and modified low-density lipoprotein (LDL).

Impact:

• Provides insight into the pathogenesis of atherosclerosis in specific genetic lipid disorders.
• Highlights the critical role of macrophages in foam cell formation and lesion development.
• Establishes a link between specific lipoprotein abnormalities and the cellular mechanisms driving cardiovascular disease.